An Essential Histidine Residue in GTP Binding Domain of Bovine Brain Glutamate Dehydrogenase Isoproteins by �씠醫낆�
Mol. Cells, Vol. 12, No. 1, pp. 121-126 
 
 
 
 
 
 
 
An Essential Histidine Residue in GTP Binding Domain of  
Bovine Brain Glutamate Dehydrogenase Isoproteins 
 
Jongweon Lee†, Jong Eun Lee1, Eun Hee Cho2, Soo Young Choi3, and Sung-Woo Cho* 
Department of Biochemistry, University of Ulsan College of Medicine, Seoul 138-736, Korea; 
1 Department of Anatomy, College of Medicine, Yonsei University, Seoul 120-749, Korea; 
2 Department of Science Education, College of Education, Chosun University, Kwangju 501-759, Korea; 
3 Department of Genetic Engineering, Division of Life Sciences, Hallym University, Chunchon 200-702, Korea. 
 
(Received February 27, 2001; Accepted April 14, 2001) 
 
Greater than 90% of the original activity of the en-
zymes remained after modification of histidine resi-
dues of glutamate dehydrogenase (GDH) isoproteins 
from bovine brains with diethyl pyrocarbonate 
(DEPC). This suggests that the DEPC modified 
histidine residues are not critically involved in the ca-
talysis of the GDH isoproteins. The influence of DEPC 
modified histidine residue(s) on binding of GTP to 
GDH isoproteins was investigated by protection stud-
ies. These studies showed that inhibition of GDH 
isoproteins by GTP was protected by preincubation of 
GDH isoproteins with DEPC. The amount of protec-
tion was dependent on the concentration of DEPC. 
The GTP inhibition was fully protected by 
preincubation of GDH isoproteins with DEPC at satu-
rating concentrations. These results indicate that the 
histidine residues may play an important role in the 
GTP binding on GDH isoproteins. Spectrophotometric 
studies showed that three histidine residues per en-
zyme subunit were able to react with DEPC in the ab-
sence of GTP, whereas two histidine residues per en-
zyme subunit interacted with DEPC when the enzymes 
were preincubated with GTP. These results indicate 
that one of the histidine residues is involved in the 
GTP binding domain of GDH isoproteins. The quanti-
tative affinity chromatographic studies showed that 
the influence of GTP on the binding of GDH 
isoproteins to DEPC-Sepharose was significantly dis-
tinct for the two GDH isoproteins. GDH I was more 
sensitively affected by GTP than GDH II in the 
binding affinity for 
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DEPC-Sepharose. ADP, another well-known allosteric  
regulator, showed no significant changes in the inter-
action of DEPC with GDH isoproteins. 
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Introduction 
 
Glutamate dehydrogenase (GDH) is found in nearly every 
organism and plays a pivotal role in nitrogen and carbon 
metabolism (Hudson and Daniel, 1993). GDH feeds the 
tricarboxylic acid cycle by converting L-glutamate to 2-
oxoglutarate in the oxidative deamination reaction. It also 
supplies nitrogen for several biosynthetic pathways in the 
reductive animation reaction (Smith et al., 1975). Recent-
ly, it was reported that the hyperinsulinism-hyperam-
onemia syndrome is caused by mutations in the GDH 
gene (Miki et al., 2000; Stanley et al., 1998). Infants with 
this disorder produce forms of GDH that are much less 
sensitive to inhibition by GTP, which demonstrates that 
the allosteric regulation of GDH plays a crucial role in 
vivo. It was proposed that this altered form of GDH would 
lead to higher oxidation rates due to increased levels of 2-
oxoglutarate. This in turn would increase the ATP/ADP 
ratio in the pancreatic β cells that, via the ATP-induced 
closure of potassium channels, leads to the release of 
stored insulin granules. 
   The study of GDH is also of particular interest since the 
enzyme activity was altered in patients with neurodegen-
erative disorders that were characterized by multisystem 
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dehydrogenase.  
atrophy and the predominant involvement of the cerebel-
lum and its connections (Hussain et al., 1989; Plaitakis et 
al., 1984). The enzyme, isolated from one of the patients 
with a variant form of multisystem atrophy, displayed a 
marked reduction of one of the GDH isoproteins 
(Mavrothalassitis et al., 1988; Plaitakis et al., 1993). 
GDH is differentially distributed as various catalytically 
active isoforms of the enzyme (Abe et al., 1992; Colon et 
al., 1986; Plaitakis et al., 1993). Although the origin of 
the GDH polymorphism is unknown, the presence of dif-
ferently sized mRNAs, and multiple gene copies for hu-
man GDH, has been reported (Amuro et al., 1988; 
Michaelidis et al., 1993; Shashidharan et al., 1994). Pre-
viously, Shashidharan et al. (1994) reported the presence 
of two human GDH-specific genes that encode highly 
homologous polypeptides. The one gene is expressed in 
all tissues, designated GLUD1 (housekeeping GDH), 
whereas the other gene is expressed specifically in neural 
and testicular tissues, designated GLUD2 (nerve tissue-
specific GDH). According to their observations, the nerve 
tissue-specific GDH is relatively thermolabile. Recently, 
it was also reported that nerve tissue-specific, and house-
keeping human GDHs, are regulated by distinct allosteric 
mechanism (Plaitakis et al., 2000; Shashidharan et al., 
1997).  
   It is essential to have a detailed structural and functional 
description of the human GDH to elucidate the patho-
physiological nature of the GDH related disorders. We 
isolated and characterized two types of GDH isoproteins 
(GDH I and GDH II) from bovine brains (Cho et al., 
1995; Choi et al., 1999). Our work led to the finding that 
the two GDH isoproteins from bovine brains were differ-
ently regulated by ADP. Also, GDH I is relatively 
thermolabile, whereas GDH II shows a much longer half-
life in heat-inactivation experiments (Cho et al., 1995). 
We also identified several residues that are important for 
substrate and regulatory binding sites, and for catalysis 
using chemical modifications and photolabeling tech-
niques (Ahn et al., 1999; Cho and Yoon, 1999; Cho et al., 
1996; 1998; 1999; Kim et al., 1997). In the present work, 
we report the involvement of a histidine residue in the 
GTP binding domain of brain GDH isoproteins by a com-
bination of chemical modification and quantitative affini-
ty chromatography. 
 
 
Materials and Methods 
 
Materials  NADH, 2-oxoglutarate, glutamate, ADP, GTP, and 
DEPC were purchased from Sigma (USA). AH-activated 
Sepharose 4B was from Amersham Pharmacia Biotech (Swe-
den). Bovine brains were obtained from Majang Slaughterhouse 
(Korea). GDH isoproteins were purified from bovine brains by 
the method developed in our laboratory (Cho et al., 1995). They 
were homogeneous, as judged by a Coomassie-stained gradient 
SDS-polyacrylamide gel electrophoresis. All other chemicals 
and solvents were reagent grade or better. 
 
Enzyme assay  GDH activity was determined 
spectrophotometrically for the reductive animation of 2-
oxoglutarate by measuring the decrease in absorbance at 340 nm, 
as described previously (Cho et al., 1995), except that no ADP 
was used unless otherwise indicated. All of the assays were 
performed in triplicate. The initial velocity data were correlated 
with a standard assay mixture that contained 50 mM 
triethanolamine, pH 8.0, 100 mM ammonium acetate, 0.1 mM 
NADH, and 2.6 mM EDTA at 25°C. One unit of enzyme was 
defined as the amount of enzyme required to oxidize 1 µmol of 
NADH per min at 25°C.  
 
Interaction of GDH with DEPC  Modification of histidine 
residues in GDH isoproteins with DEPC was performed by the 
method of Ovadi et al. (1967). Briefly, a total of 500 µg of 
enzyme was incubated at 25°C with various concentrations of 
DEPC in 25 mM HEPES, pH 6.0 in the presence and absence 
of 100 µM GTP with a final volume of 1 ml. DEPC was dis-
solved in 95% ethanol. The final concentration of ethanol was 
kept below 5% during the incubation of the enzyme with the 
modifying agent. The DEPC concentration was diluted at least 
10-fold during the assay for GDH activity. The formation of 
N-carbethoxyhistidyl was monitored at 240 nm with the ex-
tinction coefficient of 3200 M-1cm-1 at 240 nm (Ovadi et al., 
1967). 
 
Quantitative affinity chromatography  Affinity matrix, and 
quantitative affinity chromatography, was prepared by coupling 
of DEPC to AH-activated Sepharose 4B, as described by Vero-
nese et al. (1979). Affinity chromatographic elutions were per-
formed in the dark with a column of 1 × 15 cm bed volume at 
4°C. The 0.5 ml fractions were collected at a flow rate of 9 ml/h. 
GDH isoproteins (0.15 mg each) in an eluting buffer (20 mM 
potassium phosphate, pH 8.0 containing 0.1 mM EDTA and 10 
mM 2-mercaptoethanol) were applied to the column that was 
equilibrated with the eluting buffer that contained corresponding 
concentrations of DEPC. The elution position of GDH was de-
termined by assays of fractions for GDH activity using NADH, 
as described previously. The variation of enzyme elution volume 
with DEPC was plotted according to the following equation, as 
previously reported by Veronese et al. (1979), 
 
  1/(V - Vo) = [L]KLM/KL(Vo - Vm)[LM] + KLM/(Vo - Vm)[LM]  
(Eq. 1) 
 
where V, protein elution volume; Vo, volume at which protein 
elutes in the absence of interaction; Vm, void volume as deter-
mined by Blue Dextran 2000; [L], concentration of soluble lig-
and; [LM], concentration of immobilized ligand; KLM, dissocia-
tion constant for the immobilized ligand-protein interaction; and 
KL, dissociation constant for the soluble ligand-protein interac-
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tion. KL values were calculated from the ratio of ordinate inter-
cept to the slope of 1/(V - Vo) vs [L] plots. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Effects of DEPC on the activities of GDH isoproteins. 
DEPC was added to the GDH isoprotein solution in 25 mM 
HEPES, pH 6.0 at 25°C. At indicated times, the remaining activ-
ities were determined and expressed as a percentage of each 
control. All data represent mean values ± standard deviation 
from three independent experiments. , GDH I only; , GDH I 
+ 100 µM DEPC; , GDH II only; , GDH II + 100 µM DEPC. 
Error bars are omitted for clarity. 
 
 
Results and Discussion 
 
In this study, we identified the involvement of a histidine 
residue in the GTP binding domain of brain GDH 
isoproteins by a combination of chemical modification 
and quantitative affinity chromatography. We used DEPC 
for the modification studies of histidine residues, because 
of its specificity. DEPC specifically reacts with histidine 
residues in proteins at pH 6.0 and yields an 
ethoxycarbonyl derivative with a characteristic absorption 
maximum at 240 nm (Pradel and Kassab, 1968). When 
the purified GDH isoproteins were incubated with DEPC 
up to 0.1 mM at 25°C, greater than 90% of the original 
activity of the GDH isoproteins remained (Fig. 1). These 
results suggest that the DEPC modified histidine residues 
are not critically involved in the catalysis of the GDH 
isoproteins. The influence of DEPC modified histidine 
residue(s) on the binding of GTP to GDH isoproteins was 
investigated by protection studies. The GDH isoproteins 
were preincubated with DEPC at various concentrations, 
and the aliquots of the mixtures were tested for GTP inhi-
bition. The results in Fig. 2 show that the inhibition by 
GTP was protected by preincubation of the GDH 
isoproteins with DEPC. The amount of protection was 
dependent on the concentration of DEPC. The GTP inhi-
bition was fully protected by preincubation of GDH 
isoproteins with DEPC at higher than 30 µM (Fig. 2). 
These results indicate that the histidine residue(s) may 
play an important role in the GTP binding on GDH 
isoproteins. 
   As estimated from a molar absorption coefficient of 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Effects of preincubation of GDH I (A) and GDH II (B) 
with DEPC on the inhibition by GTP. Enzymes were 
preincubated with various concentrations of DEPC at 25°C in 25 
mM HEPES, pH 6.0. Aliquots of the mixtures were assayed and 
the inhibition of GDH isoproteins by GTP at a final concentra-
tion of 10 µM was measured. All data are expressed as a per-
centage of each control and represent mean values ± standard 
deviation from three independent experiments. Final concentra-
tions of DEPC were: , 0 µM; , 5 µM; , 10 µM; , 30 µM; 
and , 50 µM. 
 
 
3200 M-1cm-1 at 240 nm, three histidine residues per en-
zyme subunit was able to react with DEPC in the absence 
of GTP, whereas two histidine residues per enzyme subu-
nit interacted with DEPC when the enzymes were prein-
cubated with 0.1 mM GTP (Table 1). The results indicate 
that one of the histidine residues is involved in the bind-
ing of GTP on GDH. In contrast to the effects of GTP, 
ADP showed no significant changes in the interaction of 
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DEPC with GDH isoproteins (Table 1). It was reported 
that DEPC might react under certain conditions, not only 
with the imidazole group, but also with tyrosyl residues 
Table 1. Effects of treatment of GDH isoproteins with GTP or 
ADP on the DEPC binding to the enzymes. 
Treatment 
[DEPC]/[subunit enzyme] 
GDH 1 GDH II 
Enzyme only 0.1 0.1 
Enzyme + DEPC 3.2 2.5 
(Enzyme + GTP) + DEPC 1.9 1.9 
(Enzyme + ADP) + DEPC 3.1 2.6 
 
 
(Miles, 1977), and that the O-carbethoxylation of tyrosyl 
residues would result in a decrease of the difference ab-
sorbance at 278 nm (Burstein et al., 1974). In the present 
study, absorption spectra that were taken in the near UV 
region (270−300 nm) are identical for both DEPC-reacted 
and intact enzymes (data not shown). This suggests that 
no modification of tyrosine has taken place. 
   To further investigate the effects of GTP on the binding 
of DEPC to GDH isoproteins, we undertook the direct 
characterization of the presumed binding processes by 
quantitative affinity chromatography on DEPC-Sepha-
rose. The quantitative results with DEPC-Sepharose 
(shown in Fig. 3) provide further evidence for the regula-
tory property of GTP on the interaction of DEPC with 
GDH isoproteins. GTP was added in separate experiments 
to the eluting buffer at concentrations of 0.1 mM. The 
results in Fig. 3 show that a reduction of the elution vol-
ume of GDH isoproteins were observed. Also, their bind-
ing affinity was significantly changed in the presence of 
0.1 mM GTP. The influence of GTP on the binding of 
GDH isoproteins to DEPC-Sepharose was significantly 
distinct for the two isoproteins. Figure 3 shows GDH I 
and the binding affinities for DEPC-Sepharose. The dif-
ferences in the sensitivities to GTP between the two GDH 
isoproteins (Figs. 2 and 3) may be due to their micro-
environmental structures. For instance, previous sequence 
data has suggested that residue 452 is Ala in GDH I, but 
Gly in GDH II (Cho et al., 1996). The role of the Ala or 
Gly at the 452 position in the GTP binding to the GDH 
isoproteins remains to be studied. ADP, another well-
known allosteric regulator of GDH, did not modify the 
elution volume of GDH isoproteins when added to the 
eluting buffer (data not shown). This suggests that com-
petitive binding between ADP and DEPC does not occur. 
These results are consistent with those of protection stud-
ies (Table 1). 
   The enzyme activity of GDH is strictly regulated by 
allosteric regulators. Recent structural studies have pro-
posed that most allosteric regulation is mediated by con-
trol of the mobility of the NAD+-binding domain. GTP 
inhibits the enzyme by promoting substrate binding, while 
ADP activates it by facilitating product release (Dieter et 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Influence of GTP on the binding of GDH isoproteins to 
DEPC-Sepharose. 1/(V−Vo) against the total soluble DEPC con-
centration is plotted in the presence of varying amounts of GTP. 
Protein elution volume (V) was determined from the affinity 
chromatography elution profiles of GDH isoproteins on DEPC-
Sepharose in the presence of varying concentrations of soluble 
DEPC in the elution buffer. The concentrations of GTP used are: 
, 0 µM; , 50 µM; and , 100 µM. All data represent mean 
values ± standard deviation for the three separate experiments. 
A. GDH I. B. GDH II. 
 
 
al., 1980; Koberstein and Sund, 1973). When GTP binds 
to the allosteric site, the conformation of the NAD+-
binding domain favors the closed position over the bound 
substrate or product. In contrast, ADP facilitates the open-
ing of the active site cleft, thereby promoting substrate or 
product release. The importance of the allosteric regula-
tions of GDH was further focused on recent reports of 
hyperinsulinism-hyperammonemia. It was reported that 
the hyperinsulinism-hyperammonemia syndrome is caused 
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by single mutations in the GDH gene that affects enzyme 
sensitivity to GTP-induced inhibition (Miki et al., 2000; 
Stanley et al., 1998). One of the mutations is a replace-
ment of His450 with Tyr450. Recent atomic structures of 
bovine liver GDH (Smith et al., 2001) indicate that His 
450 (His454 in human sequence) lies on the pivot helix, 
and its side chain atom interacts with a β-phosphate of 
GTP. Therefore, the His450 mutation probably causes a 
steric interference with GTP binding. This suggests the 
importance of GTP and the regulation of GDH activity in 
the mammalian system. Although the precise His residue 
is not identified in the present work, it may be possible 
that His450 is responsible for DEPC modification and 
GTP binding. Further understanding of the mechanism 
and details of the regulation will help us to elucidate the 
metabolic role that GDH has in cellular homeostasis. 
   It was reported that the presence of two human GDH-
specific genes encodes highly homologous polypeptides 
(Shashidharan et al., 1994). The one gene, designated 
GLUD1 (housekeeping GDH), is expressed in all tissues, 
whereas the other gene, designated GLUD2 (nerve tissue-
specific GDH), is expressed specifically in neural and 
testicular tissues. According to their observations, the 
nerve tissue-specific GDH is relatively thermolabile. Sim-
ilar results have reported that bovine brain GDH I is rela-
tively thermolabile. However, GDH II shows a much 
longer half-life in heat-inactivation experiments, and 
GDH I and GDH II are differently regulated by ADP and 
GTP (Cho et al., 1995; 1996). Recently, it was also re-
ported that nerve tissue-specific, and housekeeping hu-
man GDHs, are regulated by a distinct allosteric mecha-
nism (Plaitakis et al., 2000; Shashidharan et al., 1997). 
The data in the present work show that the sensitivity of 
GDH I (relatively thermolabile form) to interaction with 
DEPC in the presence of GTP was significantly higher 
than that of GDH II (relatively thermostable form). These 
observations are consistent with previous reports that 
there are at least two different GDH activities that differ 
in their relative thermal stability and allosteric regulation 
characteristics (Abe et al., 1992; Plaitakis et al., 1984). 
These results suggest that the thermolabile GDH isotype 
has evolved into a more highly regulated enzyme. Also, 
the regulatory properties of GTP may be of importance 
for regulating glutamate fluxes in vivo under changing 
energy demands. 
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